Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder

Summary

This study aimed to evaluate the therapeutic benefits of pentoxifylline (PTX) in treatment of adult patients with MDD as it has anti-inflammatory and phosphodiastrase inhibition activities.

Timeline

Start

2015-04-20

Primary completion

2017-12-01

Completion

2018-12-31

Drugs

Indications